What Atrium Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 8 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 252,500 |
| Disposed | 210,974 | 210,974 |
| Net activity | −210,974 | +41,526 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Younis Husam | Chief Scientific Officer | Sep 18 | Withheld — tax / exercise cost · F | −11,216 | $8.95 | −$100K | 41,441 |
| Flanagan W. Michael | Director | Sep 18 | Withheld — tax / exercise cost · F | −22,812 | $8.95 | −$204K | 31,974 |
| Kenney Stephanie | See Remarks | Sep 18 | Withheld — tax / exercise cost · F | −2,375 | $8.95 | −$21.3K | 33,085 |
| Gallagher Kathleen P. | See Remarks | Sep 18 | Withheld — tax / exercise cost · F | −11,632 | $8.95 | −$104K | 119,729 |
| Hoyos Rocio Martin | Chief Strategy Officer | Sep 18 | Withheld — tax / exercise cost · F | −8,320 | $8.95 | −$74.5K | 38,340 |
| Winslow Brendan R. | Chief Financial Officer | Sep 18 | Withheld — tax / exercise cost · F | −6,742 | $8.95 | −$60.3K | 36,859 |
| Boyce Sarah | Director | Sep 18 | Withheld — tax / exercise cost · F | −126,418 | $8.95 | −$1.13M | 138,668 |
| Hughes Steven George | Chief Medical Officer | Sep 18 | Withheld — tax / exercise cost · F | −21,459 | $8.95 | −$192K | 51,638 |
| Hoyos Rocio Martin | Chief Strategy Officer | Apr 20 | Grant / award · A | +30,000 | — | — | 46,660 |
| Kenney Stephanie | See Remarks | Apr 20 | Grant / award · A | +30,000 | — | — | 35,460 |
| Younis Husam | Chief Scientific Officer | Apr 20 | Grant / award · A | +30,000 | — | — | 52,657 |
| Winslow Brendan R. | Chief Financial Officer | Apr 20 | Grant / award · A | +30,000 | — | — | 43,601 |
| Gallagher Kathleen P. | See Remarks | Apr 20 | Grant / award · A | +102,500 | — | — | 131,361 |
| Hughes Steven George | Chief Medical Officer | Apr 20 | Grant / award · A | +30,000 | — | — | 73,097 |
Loading...
